Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 706, pseudogene (RNU6-706P), is a **pseudogene** derived from the highly conserved U6 small nuclear RNA (snRNA) gene family, which encodes the RNA components of the spliceosomal U6 snRNP[1][5]. Like other U6 snRNA pseudogenes, RNU6-706P has lost its ability to code for a functional snRNA through accumulation of disabling mutations or retrotransposition and therefore does not participate in the splicing of pre-mRNA[2][5]. While some pseudogenes can regulate the expression of their parental genes or act as competing endogenous RNAs, there is no evidence that RNU6-706P itself is functionally active or implicated in disease or therapeutic targeting[2]. Its presence mainly reflects genomic evolutionary history and retrotransposon activity involving U6 snRNA sequences[5]. **Note:** - The canonical, functional U6 snRNA is indispensable for pre-mRNA splicing in eukaryotes, forming a core catalytic component of the spliceosome[1][3]. - RNU6-706P, as a pseudogene, does not encode a spliceosomal RNA and is not considered a drug target or biomarker.
Not applicable (no known drugs interact directly with this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 706, pseudogene (RNU6-706P).